• 46
  • 3
  • 收藏

Moderna’s Long-Term Benefit Is Cursed by Short-Term Thinking

InvestorPlace2021-12-16

Moderna(NASDAQ:MRNA) stock is dropping after results for its mRNA flu vaccine is underwhelming investors. However, in my opinion, the real problem is that the flu underwhelms investors. Since the ...

网页链接

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论3

  • Universe宇宙
    ·2021-12-16
    This paragraph is so hilarious!"But if you believe that the company's mRNA vaccine is just an early-stage payoff for a much grander vision that the company's pipeline outlines, then I'd encourage you tothen I'd encourage you to buy every dip in MRNA stock until the company proves it can't make its vision a reality."
    回复
    举报
    收起
    查看更多 2 条评论
  • AthanasiusT
    ·2021-12-16
    Cool cool
    回复
    举报
  • Jasonngui
    ·2021-12-16
    Cool
    回复
    举报
    收起
    • ca4edf9
      Ok
      2021-12-16
      回复
      举报
    • Jasonngui
      [Cool][Cool][Cool]
      2021-12-16
      回复
      举报
 
 
 
 

热议股票

 
 
 
 
 

7x24